Protective Effect of Oral L-arginine Supplementation on Cyclosporine Induced Nephropathy in Rats
- 1 September 2005
- journal article
- Published by Springer Nature in International Urology and Nephrology
- Vol. 37 (3) , 587-594
Abstract
Background: One of the major adverse effects of long term cyclosporine A (CyA) administration is chronic nephrotoxicity. Several studies have suggested that alterations of the L-arginine (L-Arg) nitric oxide (NO) pathway may be involved in the pathogenesis of CyA-induced kidney damage. Aim: We postulated that in vivo activation of L-Arg-NO pathway might have a beneficial effect on CyA-induced renal damage. Conditions of chronic NO enhancement was established with L-Arg supplementation and chronic NO blockade with N-nitro-L-Arg methyl ester (L-NAME). We tested the hypothesis that, if CyA administration alters intrarenal NO synthesis, then exogenous L-Arg supplementation could limit renal injury, on the contrary, L-NAME, a potent competitive inhibitor of NO synthesis, could enhance CyA nephrotoxicity. Harmful effect of NO blockade indirectly supports the beneficial effect of NO in a model of CyA nephrotoxicity. Methods: Rats were administered vehicle (VH), CyA (7.5 mg/kg/day), CyA + L-Arg (2g/kg/day), CyA + L-NAME (5 mg/100 ml/day), CyA + L-Arg + L-NAME, VH + L-Arg, VH + L-NAME and were sacrificed at the end of the experiment. Body weight, serum creatinine, blood urea nitrogen (BUN) and NO levels were determined. Tubular injury and interstitial fibrosis were evaluated semiquantitatively using scoring systems on paraffin sections stained with hematoxylin/eosin (H/E), Masson’s trichromic and periodic acid-Schiff (PAS). Results: The CyA group developed marked renal injury, characterized by a significant increase in serum creatinine and BUN, and histopathological alterations including tubular dilatation, vacuolization, necrosis, interstitial cell infiltration and tubulointerstitial fibrosis. CyA reduced serum NO level. L-Arg treatment significantly enhanced NO biosynthesis and protected animals from CyA-induced kidney damage. In contrast L-NAME strikingly reduced serum NO level, and worsened biochemical and histopathological alterations. Conclusion: Chronic CyA nephrotoxicity can be aggravated by NO blockade and ameliorated by NO enhancement suggesting that L-Arg supplementation may be protective in CyA nephrotoxicity.Keywords
This publication has 32 references indexed in Scilit:
- Cyclosporine induces different responses in human epithelial, endothelial and fibroblast cell culturesKidney International, 2000
- Cyclosporin-induced endothelial dysfunction and hypertension: are nitric oxide system abnormality and oxidative stress involved?Transplant International, 2000
- TRANSFORMING GROWTH FACTOR (TGF)-?? MIMICS AND ANTI-TGF-?? ANTIBODY ABROGATES THE IN VIVO EFFECTS OF CYCLOSPORINETransplantation, 1999
- Angiotensin II blockade decreases TGF-β1 and matrix proteins in cyclosporine nephropathyKidney International, 1997
- Sodium depletion enhances fibrosis and the expression of TGF-β1 and matrix proteins in experimental chronic cyclosporine nephropathyAmerican Journal of Kidney Diseases, 1997
- Increased renal tubular expression of transforming growth factor beta in human allografts correlates with cyclosporine toxicityKidney International, 1996
- Chronic cyclosporine nephropathy: The Achilles' heel of immunosuppressive therapyKidney International, 1996
- CLINICALLY RELEVANT DOSES AND BLOOD LEVELS PRODUCE EXPERIMENTAL CYCLOSPORINE NEPHROTOXICITY WHEN COMBINED WITH NITRIC OXIDE INHIBITION1Transplantation, 1996
- Cellular proliferation and macrophage influx precede interstitial fibrosis in cyclosporine nephrotoxicityKidney International, 1995
- Cyclosporine A induced arteriolopathy in a rat model of chronic cyclosporine nephropathyKidney International, 1995